ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $940,510 | -9.9% | 34,654 | +2.0% | 0.01% | -10.0% |
| Q2 2023 | $1,044,269 | -7.7% | 33,971 | +8.1% | 0.01% | -16.7% |
| Q1 2023 | $1,131,918 | -7.5% | 31,416 | +1.4% | 0.01% | -7.7% |
| Q4 2022 | $1,224,132 | -11.6% | 30,975 | -10.1% | 0.01% | -18.8% |
| Q3 2022 | $1,384,000 | -18.6% | 34,446 | -14.8% | 0.02% | 0.0% |
| Q2 2022 | $1,700,000 | -17.8% | 40,440 | -23.8% | 0.02% | +23.1% |
| Q1 2022 | $2,067,000 | -13.5% | 53,044 | -11.5% | 0.01% | 0.0% |
| Q4 2021 | $2,389,000 | +102.6% | 59,946 | +83.8% | 0.01% | +85.7% |
| Q3 2021 | $1,179,000 | -11.1% | 32,621 | +0.8% | 0.01% | -12.5% |
| Q2 2021 | $1,326,000 | +6.2% | 32,356 | +13.0% | 0.01% | -11.1% |
| Q1 2021 | $1,249,000 | +29.8% | 28,623 | +49.0% | 0.01% | +28.6% |
| Q4 2020 | $962,000 | – | 19,212 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |